title: Penile paraffinoma developing during treatment with pegylated interferon alfa-2a for chronic hepatitis C virus infection.
authors: Claude
authors: C
authors: Bachmeyer
authors: Philippe
authors: P
authors: Moguelet
authors: Thierry
authors: T
authors: Gombeaud
authors: Emilie
authors: E
authors: Sbidian
authors: Sélim
authors: S
authors: Aractingi
mesh_terms: D000328:Adult; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D019818:Clavulanic Acid / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D015745:Granuloma, Foreign-Body / Q000175:diagnosis; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008899:Mineral Oil / Q000009:adverse effects*; D010409:Penile Diseases / Q000139:chemically induced* / Q000175:diagnosis; D011092:Polyethylene Glycols / Q000009:adverse effects* / Q000627:therapeutic use; D011994:Recombinant Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012254:Ribavirin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D011994:Recombinant Proteins; D019818:Clavulanic Acid; D011092:Polyethylene Glycols; D012254:Ribavirin; D008899:Mineral Oil; D000658:Amoxicillin; C100416:peginterferon alfa-2a